CDC42 binding protein kinase alpha (CDC42BPA) Human shRNA Plasmid Kit (Locus ID 8476)
CAT#: TR320581
CDC42BPA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
Product images
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | CDC42 binding protein kinase alpha (CDC42BPA) Human shRNA Plasmid Kit (Locus ID 8476) |
Locus ID | 8476 |
UniProt ID | Q5VT25 |
Synonyms | MRCK; MRCKA; PK428 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | CDC42BPA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 8476). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_003607, NM_014826, NM_003607.1, NM_003607.2, NM_003607.3, NM_014826.2, NM_014826.3, NM_014826.4, BC008677, BC038993, BC050335, BC127831, BC136333, BC156892, NM_001366010, NM_001366011, NM_001366019, NM_003607.4 |
Summary | The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase contains multiple functional domains. Its kinase domain is highly similar to that of the myotonic dystrophy protein kinase (DMPK). This kinase also contains a Rac interactive binding (CRIB) domain, and has been shown to bind CDC42. It may function as a CDC42 downstream effector mediating CDC42 induced peripheral actin formation, and promoting cytoskeletal reorganization. Multiple alternatively spliced transcript variants have been described. [provided by RefSeq, Sep 2018] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |
其它CDC42BPA产品